Home > Boards > US Listed > Biotechs > NantKwest (NK)

I was still able to open it. I

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
wilma6311 Member Profile
 
Followed By 87
Posts 10,388
Boards Moderated 0
Alias Born 07/22/11
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2019 4:04:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:48:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:45:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:42:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:40:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:36:37 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/7/2019 4:32:37 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 4:07:44 PM
Cheryl Cohen Appointed to NantKwest’s Board of Directors Business Wire - 6/6/2019 4:10:00 PM
NantKwest Announces Durable Complete Responses in Multiple Advanced-Stage Solid Tumor Cancers Following Off-the-Shelf NK Cell... Business Wire - 6/4/2019 8:00:00 AM
NantKwest Announces Updated Clinical Results for Nanatinostat (VRx-3996), a Novel HDAC Inhibitor Being Developed in Partnersh... Business Wire - 6/4/2019 7:45:00 AM
NantKwest Launches First-in-Human Targeted NK Phase I Clinical Trial of CD19 T-haNK Cell Therapy in Lymphoma Patients Business Wire - 6/3/2019 2:50:00 PM
NantKwest to Present and Provide Update at Upcoming Jefferies 2019 Annual Healthcare Conference Business Wire - 6/3/2019 8:00:00 AM
NantKwest, NantCell & NantOmics to Provide Updated Preclinical & Clinical Data in Four Abstracts at Part of the American Soci... Business Wire - 5/31/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2019 4:10:11 PM
Brink Biologics Announces Research License Agreement with Worcester Polytechnic Institute for Use of NantKwest’s NK-92®... Business Wire - 5/1/2019 8:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/26/2019 4:13:38 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/1/2019 4:09:04 PM
NantKwest Announces New haNK Natural Killer Cell Patent Issuance Further Expanding Intellectual Property Estate Business Wire - 4/1/2019 8:00:00 AM
NantKwest Chairman & CEO Dr. Patrick Soon-Shiong Exercises $39 Million in Warrants & Options in Support of NK’s Natural Kil... Business Wire - 3/25/2019 8:00:00 AM
NantKwest Chairman & CEO Dr. Patrick Soon-Shiong to Present Vision for Next Generation Natural Killer Cell Therapies During K... Business Wire - 3/18/2019 5:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/13/2019 4:09:58 PM
NantKwest Signs Worldwide License Agreement with ProMab Biotechnologies to Exclusively Develop Select Next Generation Target... Business Wire - 3/4/2019 8:00:00 AM
NantKwest Announces Launch of Merkel Cell Carcinoma Phase II Trial Deploying Novel Triple Combination of off-the-Shelf Natura... Business Wire - 1/9/2019 8:00:00 AM
NantKwest to Host 4th Annual Investor/Analyst Day Highlighting Industry Leading R&D and Clinical Programs Business Wire - 1/5/2019 8:00:00 AM
wilma6311   Wednesday, 07/05/17 06:30:30 PM
Re: heidibrown post# 1143
Post # of 1169 
I was still able to open it. I looked at your article briefly but with all of the problems he's having and large amounts of debt he's incurring...adding hospitals to his system is like throwing buckets of water into a sinking ship.

I hope he is successful but he seems to be struggling.

If anyone says they have an investment philosophy, remind them that a monkey picked a winning portfolio over a fund manager...then fling your poop at them.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist